Wave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline Review
TheFly reported earlier on March 10 that Canaccord Genuity raised its price target for WVE to $52 from $43 while keeping a Buy rating on the stock.
Wave Life Sciences Ltd. (WVE)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 18,203,009 | $309,451,153 | +1% | 3.17% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 9,786,061 | $166,363,037 | -33% | 0.25% |
| 3. | Maverick Capital Lee Ainslie | 9,280,237 | $157,764,029 | +11% | 1.69% |
| 4. | Darwin Global Management Abhishek Trehan | 7,298,421 | $125,167,920 | 2.53% | |
| 5. | Driehaus Capital Richard Driehaus | 6,581,067 | $111,878,139 | +5% | 0.76% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.50 | 971,091 | $6,312,091.50 | 26,975,505 | 2026-03-30 | Filing | |
| $6.43 | 2,495,623 | $16,046,855.89 | 26,004,414 | 2026-03-27 | Filing | |
| $6.38 | 351,224 | $2,240,809.12 | 23,508,791 | 2026-03-26 | Filing | |
| $6.06 | 4,954,558 | $30,024,621.48 | 23,157,567 | 2026-03-26 | Filing | |
| $19.00 | 1,470,000 | $27,930,000.00 | 18,245,691 | 2025-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.00 | 15,294 | $229,410.00 | 61,867 | 2026-02-26 | Filing | |
| $15.09 | 17,900 | $270,182.60 | 61,867 | 2026-02-26 | Filing | |
| $13.45 | 3,588 | $48,258.60 | 134,385 | 2026-02-09 | Filing | |
| $13.45 | 10,480 | $140,956.00 | 275,520 | 2026-02-09 | Filing | |
| $13.45 | 1,883 | $25,326.35 | 61,867 | 2026-02-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,245,691 | $310,176,747 | 38.82% | |
| 2. | 15,135,983 | $257,311,705 | 0.01% | |
| 3. | 12,648,907 | $215,031,419 | 0% | |
| 4. | 4,744,520 | $80,656,840 | 0.13% | |
| 5. | 4,095,282 | $69,619,794 | 0.05% |
News See All
13 Best Stocks to Invest In on Robinhood for Beginners
MacroMicro reports that as of March 18, 2026, the S&P 500's forward 12-month P/E was 21.35, which was far higher than its 10-year historical average of 18.9 but slightly lower than the 22.0x reported ...
Here’s What Boosted Wave Life Sciences Ltd. (WVE) in Q4
Loomis Sayles, an investment management company, released its fourth-quarter 2025 investor letter for “Small Cap Growth Fund”. A copy of the letter is available to download here.
Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Wave Life Sciences Fourth Quarter and Full Year 2025 Earnings Conference Call.
Wave Life Sciences Ltd. (WVE): A Bull Case Theory
We came across a bullish thesis on Wave Life Sciences Ltd. on X.com by @MoneyShow.
Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings
Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the best hot stocks under $20 to buy. Wave Life Sciences Ltd.
10 Hot Stocks Under $20 to Buy
On February 24, Luke Barrs, Goldman Sachs Asset Management chief business and client officer for fundamental equities, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends and ...
Analysts Confirm Bullish Outlook on Wave Life (WVE) Over Obesity Treatment
Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 13 hot stocks to buy with the highest upside potential. On February 5, BofA initiated coverage of Wave Life Sciences Ltd.
13 Hot Stocks to Buy with the Highest Upside Potential
On average, equities are expected continue to deliver positive results in 2026, this time with greater breadth across sectors, styles, and regions, compared to the other periods of the recent bull market...
BofA Highlights WVE-007 as Primary Driver For Wave Life Sciences Ltd. (WVE)'s Growth, Projecting Peak Sales Above $11B
TheFly reported on February 5 that Bank of America (BofA) initiated coverage of WVE with a Buy rating and a price target of $38.
Hedge Fund Resource Center